protein
| binding to ITPR2, ITPR3, CABP1 (in the brain) |
|
binding to CYCS during apoptosis |
|
interacting with RYR1, RYR2, SHANK1, SHANK3 and TRPC4 |
|
interacting with TXNDC4 in a pH, redox-state and calcium-dependent manner |
|
interacting with PKD2 (modulate intracellular Ca2+ signaling) |
|
binding CIB1 (White 2006) |
|
CABP1 interacting with ITPR1 in the brain through a Ca2+-induced binding of the CABP1 C-domain to the N-terminal region of ITPR1 (residues 1-587) |
|
interaction juxtaposing the cytosolic RING domain of RNF170 with the cytosolic regions of activated ITPR1 that become ubiquitinated |
|
interaction between FKBP1A and RYR1, RYR3 and ITPR1 |
|
ITPR1, ITPR2 enhanced gluconeogenic gene expression by promoting the calcineurin-mediated dephosphorylation of CRTC2 |
|
CA8 is an allosteric inhibitor of ITPR1, which regulates intracellular calcium release fundamental to critical cellular functions including neuronal excitability, neurite outgrowth, neurotransmitter release |
|
DISC1 binds ITPR1 mRNA with ZNF385A, thereby regulating its dendritic transport for synaptic plasticity |
|
calcium-release channel that is inositol 1,4,5-trisphosphate (IP3) responsive |
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in neurodegenerative disease (olivopontocerebellar atrophy, cerebellar atrophy of Holmes type, Alzheimers disease, Friedreich's ataxia, cerebellopontine ataxia) | |